L'information par la presse

por Forney, Claude-Henry
Publicado 1968

Nucleic acid-based therapeutics for the treatment of central nervous system disorders

por McCartan, Robyn, Khorkova, Olga, Volmar, Claude-Henry, Wahlestedt, Claes
Publicado 2023

CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models

por Laporte, Vincent, Ait-Ghezala, Ghania, Volmar, Claude-Henry, Mullan, Michael
Publicado 2006

Amplifying gene expression with RNA-targeted therapeutics

por Khorkova, Olga, Stahl, Jack, Joji, Aswathy, Volmar, Claude-Henry, Wahlestedt, Claes
Publicado 2023

Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse

por Dennison, Jessica, Mendez, Armando, Szeto, Angela, Lohse, Ines, Wahlestedt, Claes, Volmar, Claude-Henry
Publicado 2023

Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research

por Dennison, Jessica L., Ricciardi, Natalie R., Lohse, Ines, Volmar, Claude-Henry, Wahlestedt, Claes
Publicado 2021

Natural antisense transcripts as drug targets

por Khorkova, Olga, Stahl, Jack, Joji, Aswathy, Volmar, Claude-Henry, Zeier, Zane, Wahlestedt, Claes
Publicado 2022

Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL (TM))

por Kemper, Christopher, Behnam, Dariush, Brothers, Shaun, Wahlestedt, Claes, Volmar, Claude-Henry, Bennett, Daniel, Hayward, Marshall
Publicado 2022

Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients

por Dennison, Jessica L., Al-Ali, Hassan, Volmar, Claude-Henry, Brothers, Shaun, Watts, Justin, Wahlestedt, Claes, Lohse, Ines
Publicado 2022

The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer’s Disease

por Magistri, Marco, Velmeshev, Dmitry, Makhmutova, Madina, Patel, Prutha, Sartor, Gregory C., Volmar, Claude-Henry, Wahlestedt, Claes, Faghihi, Mohammad Ali
Publicado 2016

Helix 8 and the i3 Loop of the Muscarinic M3 Receptor Are Crucial Sites for Its Regulation by the Gβ5-RGS7 Complex

por Karpinsky-Semper, Darla, Tayou, Junior, Levay, Konstantin, Schuchardt, Brett J., Bhat, Vikas, Volmar, Claude-Henry, Farooq, Amjad, Slepak, Vladlen Z.
Publicado 2014

Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma

por Lohse, Ines, Al-Ali, Hassan, Volmar, Claude-Henry, D. Alvarez Trotta, Annamil, Brothers, Shaun P., Capobianco, Anthony J., Wahlestedt, Claes
Publicado 2018

Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model

por Janczura, Karolina J., Volmar, Claude-Henry, Sartor, Gregory C., Rao, Sunil J., Ricciardi, Natalie R., Lambert, Guerline, Brothers, Shaun P., Wahlestedt, Claes
Publicado 2018

HDAC Inhibitors Induce BDNF Expression and Promote Neurite Outgrowth in Human Neural Progenitor Cells-Derived Neurons

por Bagheri, Amir, Habibzadeh, Parham, Razavipour, Seyedeh Fatemeh, Volmar, Claude-Henry, Chee, Nancy T., Brothers, Shaun P., Wahlestedt, Claes, Mowla, Seyed Javad, Faghihi, Mohammad Ali
Publicado 2019

A novel knockout mouse model of the noncoding antisense Brain-Derived Neurotrophic Factor (Bdnf) gene displays increased endogenous Bdnf protein and improved memory function follow...

por Modarresi, Farzaneh, Pedram Fatemi, Roya, Razavipour, Seyedeh Fatemeh, Ricciardi, Natalie, Makhmutova, Madina, Khoury, Nathalie, Magistri, Marco, Volmar, Claude-Henry, Wahlestedt, Claes, Faghihi, Mohammad Ali
Publicado 2021

Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models

por Ricciardi, Natalie R., Modarresi, Farzaneh, Lohse, Ines, Andrade, Nadja S., Newman, Ian R., Brown, Jonathan M., Borja, Caroline, Marples, Brian, Wahlestedt, Claes R., Volmar, Claude-Henry
Publicado 2023

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease

por Timmons, James A, Anighoro, Andrew, Brogan, Robert J, Stahl, Jack, Wahlestedt, Claes, Farquhar, David Gordon, Taylor-King, Jake, Volmar, Claude-Henry, Kraus, William E, Phillips, Stuart M
Publicado 2022

Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer

por Mustafi, Sushmita, Camarena, Vladimir, Qureshi, Rehana, Yoon, Hyunho, Volmar, Claude-Henry, Huff, Tyler C., Sant, David W., Zheng, Lihong, Brothers, Shaun P., Wahlestedt, Claes, Slingerland, Joyce, Wang, Gaofeng
Publicado 2019

Longevity‐related molecular pathways are subject to midlife “switch” in humans

por Timmons, James A., Volmar, Claude‐Henry, Crossland, Hannah, Phillips, Bethan E., Sood, Sanjana, Janczura, Karolina J., Törmäkangas, Timo, Kujala, Urho M., Kraus, William E., Atherton, Philip J., Wahlestedt, Claes
Publicado 2019